253 related articles for article (PubMed ID: 24040178)
1. Evaluation of the effectiveness of pregabalin in alleviating pain associated with fibromyalgia: using functional magnetic resonance imaging study.
Kim SH; Lee Y; Lee S; Mun CW
PLoS One; 2013; 8(9):e74099. PubMed ID: 24040178
[TBL] [Abstract][Full Text] [Related]
2. Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study.
Calandre EP; Morillas-Arques P; Molina-Barea R; Rodriguez-Lopez CM; Rico-Villademoros F
BMC Musculoskelet Disord; 2011 May; 12():95. PubMed ID: 21575194
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the fibromyalgia impact questionnaire at baseline as a predictor for time to pain improvement in two clinical trials of pregabalin.
Bushmakin AG; Cappelleri JC; Chandran AB; Zlateva G
Int J Clin Pract; 2013 Jan; 67(1):52-9. PubMed ID: 23241048
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.
García-Campayo J; Serrano-Blanco A; Rodero B; Magallón R; Alda M; Andrés E; Luciano JV; del Hoyo YL
Trials; 2009 Apr; 10():24. PubMed ID: 19389246
[TBL] [Abstract][Full Text] [Related]
5. Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response.
Straube S; Moore RA; Paine J; Derry S; Phillips CJ; Hallier E; McQuay HJ
BMC Musculoskelet Disord; 2011 Jun; 12():125. PubMed ID: 21639874
[TBL] [Abstract][Full Text] [Related]
6. Predictors of a favourable outcome in patients with fibromyalgia: results of 1-year follow-up.
Kim JE; Park DJ; Choi SE; Kang JH; Yim YR; Lee JW; Lee KE; Wen L; Kim SK; Choe JY; Lee SS
Clin Exp Rheumatol; 2016; 34(3):521-6. PubMed ID: 27087434
[TBL] [Abstract][Full Text] [Related]
7. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
[TBL] [Abstract][Full Text] [Related]
9. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
Arnold LM; Leon T; Whalen E; Barrett J
Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin Improves Pain Scores in Patients with Fibromyalgia Irrespective of Comorbid Osteoarthritis.
Argoff CE; Emir B; Whalen E; Ortiz M; Pauer L; Clair A
Pain Med; 2016 Nov; 17(11):2100-2108. PubMed ID: 27257288
[TBL] [Abstract][Full Text] [Related]
11. Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial.
Calandre EP; Morillas-Arques P; Rodriguez-Lopez CM; Rico-Villademoros F; Hidalgo J
Pharmacopsychiatry; 2007 Mar; 40(2):68-71. PubMed ID: 17447176
[TBL] [Abstract][Full Text] [Related]
12. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study).
Luciano JV; Guallar JA; Aguado J; López-Del-Hoyo Y; Olivan B; Magallón R; Alda M; Serrano-Blanco A; Gili M; Garcia-Campayo J
Pain; 2014 Apr; 155(4):693-702. PubMed ID: 24378880
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
[TBL] [Abstract][Full Text] [Related]
15. Estimating the economic benefits of positive shifts in fibromyalgia severity: an exploratory analysis based on modeling of clinical trial data of pregabalin.
Cappelleri JC; Bushmakin AG; Zlateva G; Chandran A
J Med Econ; 2013; 16(1):55-61. PubMed ID: 22954060
[TBL] [Abstract][Full Text] [Related]
16. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
Harnett J; Margolis J; Cao Z; Fowler R; Sanchez RJ; Mardekian J; Silverman SL
Pain Pract; 2011; 11(3):217-29. PubMed ID: 21199319
[TBL] [Abstract][Full Text] [Related]
17. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients.
Harris RE; Napadow V; Huggins JP; Pauer L; Kim J; Hampson J; Sundgren PC; Foerster B; Petrou M; Schmidt-Wilcke T; Clauw DJ
Anesthesiology; 2013 Dec; 119(6):1453-64. PubMed ID: 24343290
[TBL] [Abstract][Full Text] [Related]
18. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
[TBL] [Abstract][Full Text] [Related]
19. No effect of approved fibromyalgia drugs on the social pain (invalidation) contrary to physical pain: an open-label short-term randomized clinical trial.
Ghavidel-Parsa B; Bidari A; Rahimi A; Gharibpoor F; Khosousi MJ
Clin Rheumatol; 2022 Jan; 41(1):245-254. PubMed ID: 34420102
[TBL] [Abstract][Full Text] [Related]
20. The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome.
Russell IJ; Crofford LJ; Leon T; Cappelleri JC; Bushmakin AG; Whalen E; Barrett JA; Sadosky A
Sleep Med; 2009 Jun; 10(6):604-10. PubMed ID: 19410509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
